{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:46:15Z","timestamp":1793094375518,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T00:00:00Z","timestamp":1490313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23791737"],"award-info":[{"award-number":["23791737"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24659708"],"award-info":[{"award-number":["24659708"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22390301, 15H02563"],"award-info":[{"award-number":["22390301, 15H02563"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K15579"],"award-info":[{"award-number":["15K15579"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.euf.2017.03.013","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T22:00:37Z","timestamp":1491602437000},"page":"946-953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma"],"prefix":"10.1016","volume":"4","author":[{"given":"Shogo","family":"Hosogoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0026-4079","authenticated-orcid":false,"given":"Shingo","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumu","family":"Kusaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsuto","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Iwamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Tobisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Yoneyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yoneyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Koie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikara","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2017.03.013_bib0005","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euf.2017.03.013_bib0010","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1464-410X.2006.06524.x","article-title":"Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?","volume":"98","author":"Brown","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2017.03.013_bib0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1464-410X.2012.11649.x","article-title":"Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy","volume":"112","author":"Xylinas","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2017.03.013_bib0020","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2014.03.003","article-title":"A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma","volume":"66","author":"Leow","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2017.03.013_bib0025","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2010.32.3139","article-title":"International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial","volume":"29","author":"Griffiths","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2017.03.013_bib0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.urology.2011.01.002","article-title":"Perioperative outcomes of laparoscopic radical nephroureterectomy and regional lymphadenectomy in patients with upper urinary tract urothelial carcinoma after neoadjuvant chemotherapy","volume":"78","author":"Rajput","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.euf.2017.03.013_bib0035","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/jjco\/hys166","article-title":"A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy","volume":"42","author":"Kitamura","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.euf.2017.03.013_bib0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00345-012-0960-8","article-title":"Oncologic outcomes obtained after neoadjuvant and adjuvant chemotherapy for the treatment of urothelial carcinomas of the upper urinary tract: a review","volume":"31","author":"Cordier","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2017.03.013_bib0045","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","article-title":"Urothelial carcinoma of the bladder and the upper tract: disparate twins","volume":"189","author":"Green","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2017.03.013_bib0050","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.28655","article-title":"Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma","volume":"120","author":"Porten","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.euf.2017.03.013_bib0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/iju.13010","article-title":"Effect of preoperative chemotherapy on survival of patients with upper urinary tract urothelial carcinoma clinically involving regional lymph nodes","volume":"23","author":"Kobayashi","year":"2016","journal-title":"Int J Urol"},{"key":"10.1016\/j.euf.2017.03.013_bib0060","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/cncr.27751","article-title":"A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results","volume":"119","author":"Siefker-Radtke","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.euf.2017.03.013_bib0065","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.eururo.2015.06.044","article-title":"European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update","volume":"68","author":"Roupret","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2017.03.013_bib0070","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1470-2045(10)70275-8","article-title":"A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy","volume":"12","author":"Galsky","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euf.2017.03.013_bib0075","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s12032-014-0949-9","article-title":"Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer","volume":"31","author":"Koie","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.euf.2017.03.013_bib0080","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10147-014-0706-2","article-title":"Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer","volume":"20","author":"Yoneyama","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.euf.2017.03.013_bib0085","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.eururo.2006.05.046","article-title":"Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature","volume":"50","author":"Fahmy","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2017.03.013_bib0090","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.euf.2017.03.013_bib0095","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00001648-199505000-00014","article-title":"Optimal case-control matching in practice","volume":"6","author":"Cologne","year":"1995","journal-title":"Epidemiology"},{"key":"10.1016\/j.euf.2017.03.013_bib0100","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.euf.2017.03.013_bib0105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10549-012-2344-6","article-title":"Different prognostic significance of Ki-67 change between pre- and post-neoadjuvant chemotherapy in various subtypes of breast cancer","volume":"137","author":"Matsubara","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.euf.2017.03.013_bib0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10549-008-0081-7","article-title":"The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer","volume":"116","author":"Jones","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"Suppl 2","key":"10.1016\/j.euf.2017.03.013_bib0115","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.breast.2015.07.017","article-title":"Strategies for developing Ki67 as a useful biomarker in breast cancer","volume":"24","author":"Denkert","year":"2015","journal-title":"Breast"},{"key":"10.1016\/j.euf.2017.03.013_bib0120","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10549-016-3817-9","article-title":"Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up","volume":"157","author":"Bustreo","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.euf.2017.03.013_bib0125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.eururo.2006.12.029","article-title":"Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: results of a randomized phase 2 trial","volume":"52","author":"Dogliotti","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2017.03.013_bib0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/iju.12230","article-title":"Neoadjuvant chemotherapy with gemcitabine plus carboplatin followed by immediate radical cystectomy for muscle-invasive bladder cancer","volume":"21","author":"Ohyama","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.euf.2017.03.013_bib0135","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00280-013-2098-9","article-title":"Combination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tract","volume":"71","author":"Park","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.euf.2017.03.013_bib0140","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s10147-012-0447-z","article-title":"Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study","volume":"18","author":"Koie","year":"2013","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.euf.2017.03.013_bib0145","doi-asserted-by":"crossref","unstructured":"Fukushi K, Narita T, Hatakeyama S, et al. Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma. Int J Clin Oncol. In press. doi:10.1007\/s10147-016-1071-0.","DOI":"10.1007\/s10147-016-1071-0"},{"key":"10.1016\/j.euf.2017.03.013_bib0150","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrurol.2011.176","article-title":"Chemotherapy for bladder cancer in patients with impaired renal function","volume":"9","author":"Nicholson","year":"2012","journal-title":"Nat Rev Urol"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456917300810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456917300810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:48:10Z","timestamp":1762498090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456917300810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2405456917300810"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2017.03.013","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2017.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association of Urology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}